BOHD (drug)
BOHD, also known as 4-methyl-2,5-dimethoxy-β-hydroxyphenethylamine or as β-hydroxy-2C-D, is a drug of the phenethylamine, 2C, and BOx families. It is the β-hydroxy derivative of 2C-D.
In his book PiHKAL, Alexander Shulgin lists BOHD's dose as greater than 50mg orally and its duration as unknown. Its effects have been reported to include a marked drop in blood pressure without any change in heart rate, suggestive of adrenolytic toxicity. Higher doses were not explored and other effects not observed or described.
Chemistry
Synthesis
The chemical synthesis of BOHD has been described.
Analogues
Analogues of BOHD include BOHB, BOD, and BOB, among others.
History
BOHD was first described in the scientific literature by Beng T. Ho and colleagues in 1970. Subsequently it was described in greater detail by Alexander Shulgin in his 1991 book PiHKAL.
Canada
BOHD is a controlled substance in Canada under phenethylamine blanket-ban language.
This substance is a Drugs controlled by [the UK Misuse of Drugs Act#Class A drugs|Class A drug] under the UK Misuse of Drugs Act 1971.
United States
In the U.S., this substance is a Schedule 1 isomer of Mescaline.